SAN DIEGO — The U.S. Food and Drug Administration this week took action to increase peoples' access to rapid, at-home COVID-19 tests by issuing an emergency use authorization for a product made by a ...
Flowflex™ is a rapid test for the detection of SARS-CoV-2 antigens in anterior nasal specimens within 7 days of symptom onset or without any symptoms. This test is easy to use, accurate and is EUA for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback